SIGA — SIGA TECHNOLOGIES INC

Nasdaq · Health Care · Pharmaceuticals · CIK 1010086 ·
Last close
$2.94
Market Cap
$211.24M
52W High
$4.79
52W Low
$2.83
ADV30
778,712
Next earnings
2026-11-05
SIGA Technologies, Inc., a commercial-stage pharmaceutical company, focuses on the health security market in the United States. The company's lead product is TPOXX, an antiviral drug for the treatment of human smallpox disease caused by variola virus. SIGA Technologies, Inc. was incorporated in 1995 and is headquartered in New York, New York.

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGrossProfit OpIncomeNetIncomeAssets CashLiabilities
Jun 2026 41,002,253 23,441,068 13,905,578 12,463,434 175,736,786 117,584,444 10,446,151
Mar 2026 6,242,580 3,301,696 -5,321,164 -3,454,252 219,387,858 145,562,142 67,766,256
Dec 2025 3,794,084 -4,236,790 -9,499,735 -5,429,918 219,467,434 154,966,414 20,645,862
Sep 2025 2,620,000 -5,436,068 -10,222,579 -6,365,819 231,603,076 171,955,584 28,124,200

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$27,745,682
Investing CF
$-330,116
Financing CF
$-44,124,476
CapEx
$-355,009
Dividends Paid
$-43,275,909
Buybacks
$0
EPS Diluted TTM
$0.34
As of
2026-08-09

Balance + Analyst (yfinance extras)

Retained Earnings
$-77,978,958
Inventory
$41,110,808
Receivables
$7,170,229
ST Investments
EBIT TTM
$-11,137,900
Pretax Income TTM
$-5,510,946
Interest Exp TTM
Analysts

Yahoo Snapshot (yfinance, live)

Total Revenue
$53,658,920
EBITDA
$-10,547,417
Free Cash Flow
$-23,986,764
Enterprise Value
$101,278,088
Total Cash
$117,584,448
Total Debt
$439,397
Shares Out
71,849,716
Trailing EPS
$-0.04
Book Value
$2.30
ROE
-1.5%
ROA
-3.4%
Div Yield

Annual Trend (SEC EDGAR, last 5y)

Revenues vs Net Income (last 5y)

FY endRevenuesOpIncome NetIncomeAssetsLiabilities EquityOCF
Dec 2025 94,574,902 23,702,156 23,279,143 219,467,434 20,645,862 43,471,453
Dec 2024 138,719,350 69,983,274 59,214,216 244,337,026 28,532,263 48,761,807
Dec 2023 139,917,220 83,621,165 68,068,826 254,352,855 57,493,948 94,799,331
Dec 2022 110,775,610 42,700,166 33,904,806 195,035,923 24,875,881 41,611,062
Dec 2021

TTM Snapshot

Revenues TTM
$15,487,336
NetIncome TTM
$-25,896,367
OpCashFlow TTM
$0
Assets (Latest)
$203,443,741
Forward EPS
$1.08

Max Pain — expiry 2026-09-18 (volume-derived — Yahoo OI feed degraded)

max pain strike: $5.00 · spot: $2.94 · call volume: 88 · put volume: 115
Expected Move to 2026-09-18: ±$0.66 (22.45%) — implied range $2.28$3.60 · ATM straddle on $3.40 strike

Peers — same industry

TickerNameMarket CapLastDaily %
ANTX AN2 Therapeutics, Inc. $212.46M $5.63
TNXP Tonix Pharmaceuticals Holding Corp. $213.53M $12.45
KROS Keros Therapeutics, Inc. $213.74M $10.78
ORGO Organogenesis Holdings Inc. $214.89M $1.67
NGEN NERVGEN PHARMA CORP. $215.05M $2.00

News headlines (Yahoo Finance, 1h cache)

Siga Technologies Q2 Earnings Call Highlights
2026-08-07 12:03 · Yahoo
SIGA Reports Financial Results for Three and Six Months Ended June 30, 2026
2026-08-06 20:01 · Yahoo
Is SIGA Technologies’ (SIGA) Index Shift and ESOP Shelf Registration Reframing Its Defensive Identity?
2026-06-30 22:07 · Yahoo
Discovering SIGA Technologies And 2 Other Compelling Penny Stocks
2026-05-22 12:05 · Yahoo
SIGA Technologies (SIGA) Is Down 9.9% After Q1 Revenue Miss And Sharper Net Loss - What's Changed
2026-05-15 15:17 · Yahoo
Some Investors May Be Willing To Look Past SIGA Technologies' (NASDAQ:SIGA) Soft Earnings
2026-05-14 10:45 · Yahoo
Siga Technologies Q1 Earnings Call Highlights
2026-05-09 01:06 · Yahoo
SIGA (SIGA) Q1 2026 Earnings Call Transcript
2026-05-07 21:35 · Yahoo
SIGA Reports Financial Results for Three Months Ended March 31, 2026 and Provides Business Update
2026-05-07 20:01 · Yahoo
SIGA Technologies, Inc. Q2 2026 Earnings Call Summary
2026-08-07 12:30 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.